Literature DB >> 7438539

Non-specificity of circulating immune complexes in patients with acute and chronic liver disease.

C K Abrass, W A Border, G Hepner.   

Abstract

Circulating immune complexes have been described in viral hepatitis and primary biliary cirrhosis but their significance is unclear. Seventy-three patients with acute and chronic liver diseases were evaluated to determine the specificity of immune complex detection for a given liver disease. Immune complexes were measured by the fluid- and solid-phase Clq-binding assays. They were demonstrated frequently in all patients with liver disease, including those with viral hepatitis, alcoholic cirrhosis, chronic active and persistent hepatitis, drug-induced hepatitis and hepatic metastases. The presence of immune complexes was not specific for a given type of liver disease and did not correlate with hepatic dysfunction. We conclude that the detection of immune complexes is of no apparent diagnostic use in liver disease. Further evaluation of the antigen-antibody composition would be required to determine any pathogenic significance of the detected circulating immune complexes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7438539      PMCID: PMC1536986     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis.

Authors:  U Hopf; K H Meyer zum Büschenfelde; W Arnold
Journal:  N Engl J Med       Date:  1976-03-11       Impact factor: 91.245

2.  Hypercatabolism of the third component of complement in patients with primary biliary cirrhosis.

Authors:  B J Potter; E Elias; E A Jones
Journal:  J Lab Clin Med       Date:  1976-09

3.  Role of the liver in controlling the immunogenicity of commensal bacteria in the gut.

Authors:  H C Thomas; R N McSween; R G White
Journal:  Lancet       Date:  1973-06-09       Impact factor: 79.321

4.  Clq: rapid purification method for preparation of monospecific antisera and for biochemical studies.

Authors:  K Yonemasu; R M Stroud
Journal:  J Immunol       Date:  1971-02       Impact factor: 5.422

5.  Immune complexes in hepatocytic nuclei of HB ag-positive chronic hepatitis.

Authors:  M A Gerber; E Sarno; S J Vernace
Journal:  N Engl J Med       Date:  1976-04-22       Impact factor: 91.245

6.  Quantitative assessment of hepatic function by breath analysis after oral administration of (14C)aminopyrine.

Authors:  G W Hepner; E S Vesell
Journal:  Ann Intern Med       Date:  1975-11       Impact factor: 25.391

7.  The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes.

Authors:  J R Wands; E Mann; E Alpert; K J Isselbacher
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

8.  The glomerular mesangium. I. Kinetic studies of macromolecular uptake in normal and nephrotic rats.

Authors:  S M Mauer; A J Fish; E B Blau; A F Michael
Journal:  J Clin Invest       Date:  1972-05       Impact factor: 14.808

9.  Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.

Authors:  U E Nydegger; P H Lambert; H Gerber; P A Miescher
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

10.  Studies on antigen-antibody complexes. I. Elimination of soluble complexes from rabbit circulation.

Authors:  M Mannik; M P Arend; A P Hall; B C Gilliland
Journal:  J Exp Med       Date:  1971-04-01       Impact factor: 14.307

View more
  7 in total

1.  Circulating immune complexes and complement concentrations in patients with alcoholic liver disease.

Authors:  C Gluud; H Jans
Journal:  J Clin Pathol       Date:  1982-04       Impact factor: 3.411

2.  Circulating immune complexes in Indian childhood cirrhosis.

Authors:  V Kalra; G D Harkiss; P J Lachmann; O P Ghai
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

3.  [Circulating immune complexes before and after kidney allotransplantation].

Authors:  G Keusch; H M Vonwiller; A von Felten; F Bammatter; H R Burger; F Largiadèr; U Binswanger
Journal:  Klin Wochenschr       Date:  1984-04-16

4.  Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies.

Authors:  C Czerkinsky; W J Koopman; S Jackson; J E Collins; S S Crago; R E Schrohenloher; B A Julian; J H Galla; J Mestecky
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

5.  Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B.

Authors:  R Meliconi; M Baraldini; G F Stefanini; A Facchini; F Miglio; F Bortolotti; A Alberti; G Realdi; P Amoroso
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

6.  Circulating immune complexes in patients with diabetes mellitus.

Authors:  C K Abrass; D Heber; J Lieberman
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

7.  Chronic liver disease: the detection and characterization of circulating immune complexes.

Authors:  S E Brown; M W Steward; L Viola; C R Howard; I M Murray-Lyon
Journal:  Immunology       Date:  1983-08       Impact factor: 7.397

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.